Figure 1.

Hair cycle of normal eyelashes (left) and potential mechanisms of action of bimatoprost ophthalmic solution 0.03% on the eyelash cycle (right) (data on file, Allergan, Inc.).⁷,¹¹,¹⁴,¹⁵